Oligodendrocyte differentiation and signaling after transferrin internalization: A mechanism of action

Experimental Neurology

Volumn 248, Issue , 2013, Pages 262-274

  Pérez, María Julia ^a   Fernandez, Natalia ^a   Pasquini, Juana María ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fyn tyrosine kinase; MEK ERK pathways; Oligodendrocyte differentiation and transferrin; PI3K Akt pathway

Indexed keywords

BETA TUBULIN; CLATHRIN; CONTACTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELIN BASIC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE FYN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPIFLUORESCENCE MICROSCOPY; FEMALE; GENETIC TRANSFECTION; IMAGE PROCESSING; IMMUNOCYTOCHEMISTRY; INTERNALIZATION; MALE; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STEM CELL; WESTERN BLOTTING;

Β-TUB; Β-TUBULIN; AB-TFR; APOTRANSFERRIN; ATF; CYT B; CYTOCHALASIN B; DIII; DIIIΔ2; EH29; F3; F3-CONTACTIN; FYN; FYN TYROSINE KINASE; GAPDH; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; LY; LY294002, PI3 KINASE INHIBITOR; MBP; MDC; MEK/ERK PATHWAYS; MEK1/2 INHIBITOR; MOUSE ANTIBODY AGAINST TF RECEPTOR (AB-2) CLONE 42/6; MYELIN BASIC PROTEIN; NERVE/GLIA ANTIGEN 2; NG2; OL; OLIGODENDROCYTE DIFFERENTIATION AND TRANSFERRIN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROCYTES; OPC; PD; PD98059, MEK1/2 INHIBITOR; PDGFR-Α; PEGFP-C2-EPS15 DIII PLASMID, EPS15 DOMINANT NEGATIVE MUTANT; PEGFP-C2-EPS15 DIIIΔ2 PLASMID, EPS15 IRRELEVANT MUTANT; PEGFP-C2-EPS15 EH29 PLASMID, EPS15 DOMINANT NEGATIVE MUTANT; PHOSPHATIDYLINOSITOL 3-KINASE; PI3K; PI3K/AKT PATHWAY; PLATELET-DERIVED GROWTH FACTOR Α; PP2; PRIMARY AMINE MONODANSYLCADAVERIN; SRC FAMILY OF TYROSINE KINASES INHIBITOR; TEXAS RED-LABELED TRANSFERRIN; TF; TF-TR; TFR; TRANSFERRIN; TRANSFERRIN RECEPTOR; U0126; WM; WORTMANNIN, PI3 KINASE INHIBITOR;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CLATHRIN; FEMALE; MALE; MAP KINASE SIGNALING SYSTEM; OLIGODENDROGLIA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FYN; RATS; RATS, WISTAR; RECEPTORS, TRANSFERRIN; SIGNAL TRANSDUCTION; TRANSFERRIN;

EID: 84880619653     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.06.014     Document Type: Article

References (75)

1. Adamo A.M., Paez P.M., Escobar Cabrera O.E., Wolfson M., Franco P.G., Pasquini J.M., Soto E.F. Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin. Exp. Neurol. 2006, 198:519-529.
2. Arai K., Lo E.H. Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J. Neurosci. Res. 2010, 88:758-763.
3. Artini M., Scoarughi G.L., Cellini A., Papa R., Barbato G., Selan L. Holo and apo-transferrins interfere with adherence to abiotic surfaces and with adhesion/invasion to HeLa cells in Staphylococcus spp. Biometals 2012, 25:413-421.
4. Badaracco M.E., Ortiz E.H., Soto E.F., Connor J., Pasquini J.M. Effect of transferrin on hypomyelination induced by iron deficiency. J. Neurosci. Res. 2008, 86:2663-2673.
5. Baer A.S., Syed Y.A., Kang S.U., Mitteregger D., Vig R., ffrench-Constant C., Franklin R.J.M., Altmann F., Lubec G., Kotter M.R. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signaling. Brain 2009, 132:465-481.
6. Baron W., Metz B., Bansal R., Hoekstra D., de Vries H. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells, regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol. Cell. Neurosci. 2000, 15:314-329.
7. Bartlett W.P., Li X.S., Connor J.R. Expression of transferrin mRNA in the CNS of normal and jumpy mice. J. Neurochem. 1991, 57:318-322.
8. Benmerah A., Bayrou M., Cerf-Bensussan N., Dautry-Varsat A. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J. Cell Sci. 1999, 112:1303-1311.
9. Bibollet-Bahena O., Almazan G. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J. Neurochem. 2009, 109:1440-1451.
10. Bloch B., Popovici T., Levin M.J., Tuil D., Kahn A. Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:6706-6710.
11. Calzolari A., Raggi C., Deaglio S., Sposi N.M., Stafsnes M., Fecchi K., Parolini I., Malavasi F., Peschle C., Sargiacomo M., Testa U. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell Sci. 2006, 119:4486-4498.
12. Calzolari A., Larocca L.M., Deaglio S., Finisguerra V., Boe A., Raggi C., Ricci-Vitani L., Pierconti F., Malavasi F., De Maria R., Testa U., Pallini R. Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl. Oncol. 2010, 3:123-134.
13. Cao H., Chen J., Krueger E.W., McNiven M.A. SRC-mediated phosphorylation of dynamin and cortactin regulates the "constitutive" endocytosis of transferrin. Mol. Cell. Biol. 2010, 30:781-792.
14. Casaccia-Bonnefil P., Aibel L., Chao M.V. Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. J. Neurosci. Res. 1996, 43:382-389.
15. Chew L.J., Coley W., Cheng Y., Gallo V. Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J. Neurosci. 2010, 30:11011-11027.
16. Coelho R.P., Yuelling L.M., Fuss B., Sato-Bigbee C. Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes. Glia 2009, 57:1754-1764.
17. Cole P.A., Shen K., Qiao Y., Wang D. Protein tyrosine kinases Src and Csk, a tail's tale. Curr. Opin. Chem. Biol. 2003, 7:580-585.
18. Colognato H., Ramachandrappa S., Olsen I.M., ffrench-Constant C. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J. Cell Biol. 2004, 167:365-375.
19. Cui Q.L., Almazan G. IGF-I induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases. J. Neurochem. 2007, 100:1480-1493.
20. Cui Q.L., Zheng W.H., Quirion R., Almazan G. Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival. J. Biol. Chem. 2005, 280:8918-8928.
21. Du Y., Lercher L.D., Zhou R., Dreyfus C.F. Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. J. Neurosci. Res. 2006, 84:1692-1702.
22. Escobar Cabrera O.E., Bongarzone E.R., Soto E.F., Pasquini J.M. Single intracerebral injection of apotransferrin in young rats induces increased myelination. Dev. Neurosci. 1994, 16:248-254.
23. Escobar Cabrera O.E., Zakin M.M., Soto E.F., Pasquini J.M. Single intracranial injection of apotransferrin in young rats increases the expression of specific myelin protein mRNA. J. Neurosci. Res. 1997, 47:603-608.
24. Espinosa de los Monteros A., Kumar S., Scully S., Cole R., de Vellis J. Transferrin gene expression and secretion by rat brain cells in vitro. J. Neurosci. Res. 1990, 25:576-580.
25. Espinosa De Los Monteros A., Kumar S., Zhao P., Huang C.J., Nazarian R., Pan T., Scully S., Chang R., de Vellis J. Transferrin is an essential factor for myelination. Neurochem. Res. 1999, 24:235-248.
26. Flores A.I., Narayanan S.P., Morse E.N., Shick H.E., Yin X., Kidd G., Avila R.L., Kirschner D.A., Macklin W.B. Constitutively active Akt induces enhanced myelination in the CNS. J. Neurosci. 2008, 28:7174-7183.
27. Fyffe-Maricich S.L., Karlo J.C., Landreth G.E., Miller R.H. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J. Neurosci. 2011, 31:843-850.
28. Galvin J., Eyermann C., Colognato H. Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation. J. Neurosci. Res. 2010, 88:3295-3307.
29. Garcia C., Paez P.M., Davio C., Soto E.F., Pasquini J.M. Apotransferrin induces cAMP/CREB pathway and cell cycle exit in immature oligodendroglial cells. J. Neurosci. Res. 2004, 78:338-346.
30. Guardia Clausi M., Paez P.M., Campagnoni A.T., Pasquini L.A., Pasquini J.M. Intranasal administration of aTf protects and repairs the neonatal white matter after a cerebral hypoxic-ischemic event. Glia 2012, 60:1540-1554.
31. Guardiola-Diaz H.M., Ishii A., Bansal R. Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages ofoligodendrocyte differentiation. Glia 2012, 3:476-486.
32. Han J., Day J.R., Connor J.R., Beard J.L. Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats. Nutr. Neurosci. 2003, 6:1-10.
33. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 1996, 271:695-701.
34. Hänninen M.M., Haapasalo J., Haapasalo H., Fleming R.E., Britton R.S., Bacon B.R., Parkkila S. Expression of iron-related genes in human brain and brain tumors. BMC Neurosci. 2009, 10:36.
35. Hu J.G., Wang Y.X., Wang H.J., Bao M.S., Wang Z.H., Ge X., Wang F.C., Zhou J.S., Lü H.Z. PDGF-AA mediates B104 CM-induced oligodendrocyte precursor cell differentiation of embryonic neural stem cells through Erk, PI3K, and p38 signaling. J. Mol. Neurosci. 2012, 46:644-653.
36. Kawabata H., Germain R.S., Vuong P.T., Nakamaki T., Said J.W., Koeffler H.P. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 2000, 275:16618-16625.
37. Kawabata H., Tong X., Kawanami T., Wano Y., Hirose Y., Sugai S., Koeffler H.P. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2. Br. J. Haematol. 2004, 127:464-473.
38. Klein C., Kramer E.M., Cardine A.M., Schraven B., Brandt R., Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of Fyn kinase with the cytoskeletal protein tau. J. Neurosci. 2002, 22:698-707.
39. Krämer E.M., Klein C., Koch T., Boytinck M., Trotter J. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J. Biol. Chem. 1999, 274:29042-29049.
40. Krämer-Albers E.M., White R. From axon-glial signalling to myelination, the integrating role of oligodendroglial Fyn kinase. Cell. Mol. Life Sci. 2011, 68:2003-2012.
41. Laursen L.S., Chan C.W., ffrench-Constant C. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J. Neurosci. 2009, 29:9174-9185.
42. Lesley J.F., Schulte R.J. Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies. Mol. Cell. Biol. 1985, 5:1814-1821.
43. Marta C.B., Escobar Cabrera O.E., Garcia C.I., Villar M.J., Pasquini J.M., Soto E.F. Oligodendroglial cell differentiation in rat brain is accelerated by the intracranial injection of apotransferrin. Cell. Mol. Biol. 2000, 46:529-539.
44. McArdle H.J., Morgan E.H. The effect of monoclonal antibodies to the human transferrin receptor on transferrin and iron uptake by rat and rabbit reticulocytes. J. Biol. Chem. 1984, 259:1398-1400.
45. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980, 85:890-902.
46. Moos T., Oates P.S., Morgan E.H. Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. J. Comp. Neurol. 1998, 398:420-430.
47. Motley A., Bright N.A., Seaman M.N., Robinson M.S. Clathrin-mediated endocytosis in AP-2-depleted cells. J. Cell Biol. 2003, 162:909-918.
48. Nesterov A., Carter R.E., Sorkina T., Gill G.N., Sorkin A. Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis. EMBO J. 1999, 18:2489-2499.
49. Ohno H., Stewart J., Fournier M.C., Bosshart H., Rhee I., Miyatake S., Saito T., Gallusser A., Kirchhausen T., Bonifacino J.S. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 1995, 269:1872-1875.
50. Okada M., Makino A., Nakajima M., Okuyama S., Furukawa S., Furukawa Y. Estrogen stimulates proliferation and differentiation of neural stem/progenitor cells through different signal transduction pathways. Int. J. Mol. Sci. 2010, 11:4114-4123.
51. Ortiz E.H., Pasquini L.A., Soto E.F., Pasquini J.M. Apotransferrin and the cytoskeleton of oligodendroglial cells. J. Neurosci. Res. 2005, 82:822-830.
52. Osterhout D.J., Wolven A., Wolf R.M., Resh M.D., Chao M.V. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J. Cell Biol. 1999, 145:1209-1218.
53. Paez P.M., Marta C.B., Moreno M.B., Soto E.F., Pasquini J.M. Apotransferrin decreases migration and enhances differentiation of oligodendroglial progenitor cells in an in vitro system. Dev. Neurosci. 2002, 24:47-58.
54. Pasquini L.A., Paez P.M., Moreno M.A., Pasquini J.M., Soto E.F. Inhibition of the proteasome by lactacystin enhances oligodendroglial cell differentiation. J. Neurosci. 2003, 23:4635-4644.
55. Perez M.J., Ortiz E.H., Roffé M., Soto E.F., Pasquini J.M. Fyn kinase is involved in oligodendroglial cell differentiation induced by apotransferrin. J. Neurosci. Res. 2009, 15:3378-3389.
56. Poli M., Luscieti S., Gandini V., Maccarinelli F., Finazzi D., Silvestri L., Roetto A., Arosio P. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica 2010, 95:1832-1840.
57. Puri C. Loss of myosin VI no insert isoform (NoI) induces a defect in clathrin-mediated endocytosis and leads to caveolar endocytosis of transferrin receptor. J. Biol. Chem. 2009, 284:34998-35014.
58. Ramey G., Deschemin J.C., Vaulont S. Crosstalk between the mitogen activated protein kinase and bone morphogenetic protein/he mojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 2009, 94:765-772.
59. Rappoport J.Z., Simon S.M., Benmerah A. Understanding living clathrin-coated pits. Traffic 2004, 5:327-337.
60. Ray E., Samanta A.K. Dansyl cadaverine regulates ligand induced endocytosis of interleukin-8 receptor in human polymorphonuclear neutrophils. FEBS Lett. 1996, 378:235-239.
61. Recht L.D., Griffin T.W., Raso V., Salimi A.R. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro. Cancer Res. 1990, 50:6696-6700.
62. Rouault T.A., Cooperman S. Brain iron metabolism. Semin. Pediatr. Neurol. 2006, 13:142-148.
63. Saleh M.C., Espinosa De Los Monteros A., de Arriba Zerpa G.A., Fontaine I., Piaud O., Djordjijevic D., Baroukh N., Garcia Otin A.L., Ortiz E., Lewis S., Fiette L., Santambrogio P., Belzung C., Connor J.R., de Vellis J., Pasquini J.M., Zakin M.M., Baron B., Guillou F. Myelination and motor coordination are increased in transferrin transgenic mice. J. Neurosci. Res. 2003, 72:587-594.
64. Stariha R.L., Kim S.U. Protein kinase C and mitogen-activated protein kinase signalling in oligodendrocytes. Microsc. Res. Tech. 2001, 6:680-688.
65. Suzuki A., Raya A., Kawakami Y., Morita M., Matsui T., Nakashima K., Gage F.H., Rodríguez-Esteban C., Izpisúa Belmonte J.C. Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat. Clin. Pract. Cardiovasc. Med. 2006, (Suppl. 1):S114-S122.
66. Todorich B., Zhang X., Slagle-Webb B., Seaman W.E., Connor J.R. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J. Neurochem. 2008, 107:1495-1505.
67. Trowbridge I.S., Lopez F. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:1175-1179.
68. Umemori H., Wanaka A., Kato H., Takeuchi M., Tohyama M., Yamamoto T. Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system. Brain Res. Mol. Brain Res. 1992, 16:303-310.
69. Umemori H., Sato S., Yagi T., Aizawa S., Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 1994, 367:572-576.
70. Umemori H., Kadowaki Y., Hirosawa K., Yoshida Y., Hironaka K., Okano H., Yamamoto T. Stimulation of myelin basic protein gene transcription by Fyn tyrosine kinase for myelination. J. Neurosci. 1999, 19:1393-1397.
71. Wally J., Buchanan S.K. A structural comparison of human serum transferrin and human lactoferrin. Biometals 2007, 20:249-262.
72. White R., Gonsior C., Krämer-Albers E.M., Stöhr N., Hüttelmaier S., Trotter J. Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules. J. Cell Biol. 2008, 181:579-586.
73. Xiao L., Guo D., Hu C., Shen W., Shan L., Li C., Liu X., Yang W., Zhang W., He C. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination. Glia 2012, 60:1037-1052.
74. Xu C., Lv L., Zheng G., Li B., Gao L., Sun Y. Neuregulin1β1 protects oligodendrocyte progenitor cells from oxygen glucose deprivation injury induced apoptosis via ErbB4-dependent activation of PI3-kinase/Akt. Brain Res. 2012, 1467:104-112.
75. Younes-Rapozo V., Felgueiras L.O., Viana N.L., Fierro I.M., Barja-Fidalgo C., Manhães A.C., Barradas P.C. A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro, stage specific effects on cell branching. Int. J. Dev. Neurosci. 2009, 27:757-768.